อ้างอิง ของ ลอราเซแพม

  1. ↑ "LORAZEPAM". The Druge Gene Interaction Database. Archived from the original on 2016-08-05. สืบค้นเมื่อ 2016-05-18. Unknown parameter |deadurl= ignored (help)
  2. ↑ Legal and Ethical Issues for Health Professions E-Book (in อังกฤษ). Elsevier Health Sciences. 2018. p. 90. ISBN 9780323550338.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 "Lorazepam". drugs.com. American Society of Health-System Pharmacists. 2016-06-29. Archived from the original on 2016-06-05. สืบค้นเมื่อ 2016-07-15. Unknown parameter |deadurl= ignored (help)
  4. ↑ Greenblatt, DJ; Shader, RI; Franke, K; Maclaughlin, DS; Harmatz, JS; Allen, MD; Werner, A; Woo, E (1991). "Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans". Journal of Pharmaceutical Sciences. 68 (1): 57–63. doi:10.1002/jps.2600680119. PMID 31453.
  5. ↑ Greenblatt, DJ; von Moltke, LL; Ehrenberg, BL; Harmatz, JS; Corbett, KE; Wallace, DW; Shader, RI (2000). "Kinetics and dynamics of lorazepam during and after continuous intravenous infusion". Critical Care Medicine. 28 (8): 2750–2757. doi:10.1097/00003246-200008000-00011. PMID 10966246.
  6. ↑ Papini, O; da Cunha, SP; da Silva Mathes Ado, C; Bertucci, C; Moisés, EC; de Barros Duarte, L; de Carvalho Cavalli, R; Lanchote, VL (2006). "Kinetic disposition of lorazepam with a focus on the glucuronidation capacity, transplacental transfer in parturients and racemization in biological samples". Journal of Pharmaceutical and Biomedical Analysis. 40 (2): 397–403. doi:10.1016/j.jpba.2005.07.021. PMID 16143486.
  7. ↑ "Lorazepam: MedlinePlus Drug Information". medlineplus.gov. 2010-10-01. Archived from the original on 2016-08-19. สืบค้นเมื่อ 2016-07-16. Unknown parameter |deadurl= ignored (help)
  8. 1 2 Dodds, Tyler J (2017-03-02). "Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature". The Primary Care Companion for CNS Disorders. 19 (2). doi:10.4088/PCC.16r02037. ISSN 2155-7780. PMID 28257172.
  9. 1 2 3 4 5 6 7 8 9 10 Riss, J; Cloyd, J; Gates, J; Collins, S (2008). "Benzodiazepines in epilepsy: pharmacology and pharmacokinetics". Acta Neurologica Scandinavica. 118 (2): 69–86. doi:10.1111/j.1600-0404.2008.01004.x. PMID 18384456.
  10. 1 2 Mets, MA; Volkerts, ER; Olivier, B; Verster, JC (2010). "Effect of hypnotic drugs on body balance and standing steadiness". Sleep Medicine Reviews. 14 (4): 259–267. doi:10.1016/j.smrv.2009.10.008. PMID 20171127.
  11. 1 2 "Ativan (lorazepam) Tablets Rx only" (PDF). Food and Drug Administration. March 2007. Archived from the original (PDF) on 2011-09-17. In general, benzodiazepines should be prescribed for short periods only (e.g. 2-4 weeks). Extension of the treatment period should not take place without reevaluation of the need for continued therapy. Continuous long-term use of product is not recommended. Unknown parameter |deadurl= ignored (help)
  12. ↑ Shorter, Edward (2005). "B". A Historical Dictionary of Psychiatry. Oxford University Press. ISBN 978-0-19-029201-0. Archived from the original on 2017-03-28. Unknown parameter |deadurl= ignored (help)
  13. ↑ "WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Archived from the original (PDF) on 2016-12-13. สืบค้นเมื่อ 2016-12-08. Unknown parameter |deadurl= ignored (help)
  14. ↑ "Lorazepam". International Medical Products Price Guide. สืบค้นเมื่อ 2019-11-29.
  15. ↑ British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 336. ISBN 9780857113382.
  16. ↑ Hamilton, Richart (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 437. ISBN 9781284057560.
  17. ↑ "The Top 300 of 2019". clincalc.com. สืบค้นเมื่อ 2018-12-22.
  18. ↑ Rabin, RC (2009-08-25). "Disparities: Study Finds Risk in Off-Label Prescribing". The New York Times. p. D6. Archived from the original on 2017-02-19. Unknown parameter |deadurl= ignored (help)
  19. ↑ Lader, M (1984). "Short-term versus long-term benzodiazepine therapy". Current Medical Research and Opinion. 8 (Suppl 4): 120–126. doi:10.1185/03007998409109550. PMID 6144459.
  20. ↑ Aschenbrenner, Diane S.; Samantha J. Venable (2009). Drug Therapy in Nursing (3rd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 273. ISBN 978-0-7817-6587-9. OCLC 173659630. Archived from the original on 2016-04-19. Unknown parameter |deadurl= ignored (help)
  21. ↑ Scharf, MB; Kales, A; Bixler, EO; Jacoby, JA; Schweitzer, PK (1982). "Lorazepam-efficacy, side effects, and rebound phenomena". Clinical Pharmacology and Therapeutics. 31 (2): 175–179. doi:10.1038/clpt.1982.27. PMID 6120058.
  22. 1 2 3 Walker, M (2005). "Status epilepticus: an evidence based guide". BMJ. 331 (7518): 673–677. doi:10.1136/bmj.331.7518.673. PMC 1226249. PMID 16179702.
  23. ↑ Prasad, Manya; Krishnan, Pudukode R.; Sequeira, Reginald; Al-Roomi, Khaldoon (2014-09-10). "Anticonvulsant therapy for status epilepticus". The Cochrane Database of Systematic Reviews (9): CD003723. doi:10.1002/14651858.CD003723.pub3. ISSN 1469-493X. PMID 25207925.
  24. ↑ Treiman, DM; Walker, MC (2006). "Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus". Epilepsy Research. 68 (Suppl 1): S77–S82. doi:10.1016/j.eplepsyres.2005.07.020. PMID 16384688.
  25. ↑ Treiman, DM (2007). "Treatment of convulsive status epilepticus". The Neurobiology of Epilepsy and Aging. International Review of Neurobiology. 81. pp. 273-285. doi:10.1016/S0074-7742(06)81018-4. ISBN 978-0-12-374018-2. PMID 17433931.
  26. ↑ Isojärvi, JI; Tokola, RA (1998). "Benzodiazepines in the treatment of epilepsy in people with intellectual disability". Journal of Intellectual Disability Research. 42 (1): 80–92. PMID 10030438.
  27. 1 2 Peppers, MP (1996). "Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease". Pharmacotherapy. 16 (1): 49–57. doi:10.1002/j.1875-9114.1996.tb02915.x (inactive 2019-08-19). PMID 8700792.
  28. ↑ Bråthen, G; Ben-Menachem, E; Brodtkorb, E; Galvin, R; Garcia-Monco, JC; Halasz, P; Hillbom, M; Leone, MA; Young, AB (2005). "EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force". European Journal of Neurology. 12 (8): 575–581. doi:10.1111/j.1468-1331.2005.01247.x. PMID 16053464.
  29. ↑ Cox, CE; Reed, SD; Govert, JA; Rodgers, JE; Campbell-Bright, S; Kress, JP; Carson, SS (2008). "An Economic Evaluation of Propofol and Lorazepam for Critically Ill Patients Undergoing Mechanical Ventilation". Critical Care Medicine. 36 (3): 706–714. doi:10.1097/CCM.0B013E3181544248. PMC 2763279. PMID 18176312.
  30. 1 2 3 4 5 Hindmarch, I (1997-01-30). "Benzodiazepines and their effects". benzo.org.uk. สืบค้นเมื่อ 2007-05-13.
  31. ↑ Maltais, F; Laberge, F; Laviolette, M (1996). "A randomized, double-blind, placebo-controlled study of lorazepam as premedication for bronchoscopy" (PDF). Chest. 109 (5): 1195–1198. doi:10.1378/chest.109.5.1195. PMID 8625666. Archived from the original (PDF) on 2008-04-07. Unknown parameter |deadurl= ignored (help)
  32. ↑ Heisterkamp, DV; Cohen, PJ (1975). "The effect of intravenous premedication with lorazepam (Ativan), pentobarbital or diazepam on recall". British Journal of Anaesthesiology. 47 (1): 79–81. doi:10.1093/bja/47.1.79. PMID 238548.
  33. ↑ Tsui, BC; Wagner, A; Finucane, B (2004). "Regional anaesthesia in the elderly: a clinical guide". Drugs Aging. 21 (14): 895–910. doi:10.2165/00002512-200421140-00001. PMID 15554749.
  34. ↑ Verhagen, EH; Hesselmann, GM; Besse, TC; de Graeff, A (2005). "(title in Dutch)" [Palliative sedation]. Nederlands Tijdschrift voor Geneeskunde (in Dutch). 149 (9): 458–461. PMID 15771339.CS1 maint: unrecognized language (link)
  35. 1 2 3 Arcangeli, A; Antonelli, M; Mignani, V; Sandroni, C (2005). "Sedation in PACU: the role of benzodiazepines". Current Drug Targets. 6 (7): 745–748. doi:10.2174/138945005774574416. PMID 16305452.
  36. 1 2 Battaglia, J (2005). "Pharmacological management of acute agitation". Drugs. 65 (9): 1207–1222. doi:10.2165/00003495-200565090-00003. PMID 15916448.
  37. ↑ Zoupanos, BN; Bryois, C (2005). "(title in French)" [Treatment of agitation in the emergency room]. Revue Médicale Suisse (in French). 1 (27): 1810–1813. PMID 16119296.CS1 maint: unrecognized language (link)
  38. ↑ Huf, G; Alexander, J; Allen, MH (2005). "Haloperidol plus promethazine for psychosis induced aggression". Cochrane Database of Systematic Reviews. 2005 (1): CD005146. doi:10.1002/14651858.CD005146. PMID 15654706.
  39. 1 2 Gillies, D; Beck, A; McCloud, A; Rathbone, J (2005). "Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis". Cochrane Database of Systematic Reviews. 2005 (4): CD003079. doi:10.1002/14651858.CD003079.pub2. PMID 16235313.
  40. 1 2 Bieniek, SA; Ownby, RL; Penalver, A; Dominguez, RA (1998). "A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation". Pharmacotherapy. 18 (1): 57–62. doi:10.1002/j.1875-9114.1998.tb03827.x (inactive 2019-08-19). PMID 9469682.
  41. ↑ Rosebush, PI; Mazurek, MF (1996). "Catatonia after benzodiazepine withdrawal". Journal of Clinical Psychopharmacology. 16 (4): 315–319. doi:10.1097/00004714-199608000-00007. PMID 8835707.
  42. ↑ van Dalfsen, AN; van den Eede, F; van den Bossche, B; Sabbe, BG (2006). "(title in Dutch)" [Benzodiazepines in the treatment of catatonia]. Tijdschrift voor Psychiatrie (in Dutch). 48 (3): 235–239. PMID 16956088.CS1 maint: unrecognized language (link)
  43. ↑ Herrstedt, J; Aapro, MS; Roila, F; Kataja, VV (2005). "ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)" (PDF). Annals of Oncology. 16 (Suppl 1): i77–i79. doi:10.1093/annonc/mdi805. PMID 15888767. Archived from the original (PDF) on 2008-03-07. Unknown parameter |deadurl= ignored (help)
  44. ↑ "Pathogenesis and Treatment of Cyclical Vomiting". 2005. PMID 16131963. Cite journal requires |journal= (help)
  45. ↑ "North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Consensus Statement on the Diagnosis and Management of Cyclic Vomiting Syndrome". 2008. PMID 18728540. Cite journal requires |journal= (help)
  46. ↑ "Cyclic vomiting syndrome in adults". 2008. PMID 18371009. Cite journal requires |journal= (help)
  47. ↑ Bishop, KI; Curran, HV (December 1998). "An investigation of the effects of benzodiazepine receptor ligands and of scopolamine on conceptual priming". Psychopharmacology. 140 (3): 345–53. doi:10.1007/s002130050775. PMID 9877014.
  48. ↑ Bishop, KI; Curran, HV (September 1995). "Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil". Psychopharmacology. 121 (2): 267–78. doi:10.1007/bf02245638. PMID 8545533.
  49. ↑ Kripke, DF (February 2016). "Mortality Risk of Hypnotics: Strengths and Limits of Evidence" (PDF). Drug Safety. 39 (2): 93–107. doi:10.1007/s40264-015-0362-0. PMID 26563222.
  50. ↑ "Ativan side effects". RxList. 2007. Archived from the original on 2007-08-21. สืบค้นเมื่อ 2007-08-10. Unknown parameter |deadurl= ignored (help)
  51. ↑ Sorel, L; Mechler, L; Harmant, J (1981). "Comparative trial of intravenous lorazepam and clonazepam im status epilepticus". Clinical Therapeutics. 4 (4): 326–336. PMID 6120763.
  52. ↑ Bond, A; Lader, M (1988). "Differential effects of oxazepam and lorazepam on aggressive responding". Psychopharmacology. 95 (3): 369–373. doi:10.1007/BF00181949. PMID 3137624.
  53. ↑ Pietras, CJ; Lieving, LM; Cherek, DR; Lane, SD; Tcheremissine, OV; Nouvion, S (2005). "Acute effects of lorazepam on laboratory measures of aggressive and escape responses of adult male parolees". Behavioural Pharmacology. 16 (4): 243–251. doi:10.1097/01.fbp.0000170910.53415.77. PMID 15961964.
  54. ↑ Kalachnik, JE; Hanzel, TE; Sevenich, R; Harder, SR (2002). "Benzodiazepine behavioral side effects: review and implications for individuals with mental retardation". American Journal of Mental Retardation. 107 (5): 376–410. doi:10.1352/0895-8017(2002)107<0376:BBSERA>2.0.CO;2. PMID 12186578.
  55. ↑ Michel, L; Lang, JP (2003). "(title in French)" [Benzodiazepines and forensic aspects]. L'Encéphale (in French). 29 (6): 479–485. PMID 15029082.CS1 maint: unrecognized language (link)
  56. ↑ Mancuso, CE; Tanzi, MG; Gabay, M (2004). "Paradoxical reactions to benzodiazepines: literature review and treatment options". Pharmacotherapy. 24 (9): 1177–1185. doi:10.1592/phco.24.13.1177.38089. PMID 15460178. Archived from the original on 2012-12-13. Unknown parameter |deadurl= ignored (help)
  57. ↑ Goldney, RD (1977). "Paradoxical reaction to a new minor tranquilizer". Medical Journal of Australia. 1 (5): 139–140. PMID 15198.
  58. ↑ Izaute, M; Bacon, E (2005). "Specific effects of an amnesic drug: effect of lorazepam on study time allocation and on judgment of learning". Neuropsychopharmacology. 30 (1): 196–204. doi:10.1038/sj.npp.1300564. PMID 15483562.
  59. ↑ Scharf, MB; Kales, A; Bixler, EO; Jacoby, JA; Schweitzer, PK (1982). "Lorazepam-efficacy, side-effects, and rebound phenomena". Clinical Pharmacology and Therapeutics. 31 (2): 175–179. doi:10.1038/clpt.1982.27. PMID 6120058.
  60. ↑ Riker, RR; Fraser, GL (2005). "Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit". Pharmacotherapy. 25 (5 Pt 2): 8S–18S. doi:10.1592/phco.2005.25.5_Part_2.8S. PMID 15899744.
  61. ↑ Guilleminault, C. (1990-03-02). "Benzodiazepines, breathing, and sleep". The American Journal of Medicine. 88 (3A): 25S–28S. doi:10.1016/0002-9343(90)90282-I. ISSN 0002-9343. PMID 1968716.
  62. ↑ Kanto, JH (1982). "Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations". Drugs. 23 (5): 354–380. doi:10.2165/00003495-198223050-00002. PMID 6124415.
  63. ↑ McElhatton, PR (1994). "The effects of benzodiazepine use during pregnancy and lactation". Reproductive Toxicology. 8 (6): 461–475. doi:10.1016/0890-6238(94)90029-9. PMID 7881198.
  64. 1 2 3 Authier, N; Balayssac, D; Sautereau, M; Zangarelli, A; County, P; Somogyi, AA; Vennat, B; Llorca, PM; Eschalier, A (2009). "Benzodiazepine dependence: focus on withdrawal syndrome". Annales Pharmaceutiques Françaises. 67 (6): 408–413. doi:10.1016/j.pharma.2009.07.001. PMID 19900604.
  65. ↑ Butler, JM; Begg, EJ (2008). "Free drug metabolic clearance in elderly people". Clinical Pharmacokinetics. 47 (5): 297–321. doi:10.2165/00003088-200847050-00002. PMID 18399712.
  66. 1 2 3 Olkkola, KT; Ahonen, J (2008). "Midazolam and other benzodiazepines". Modern Anesthetics. Handbook of Experimental Pharmacology. 182. pp. 335–360. doi:10.1007/978-3-540-74806-9_16. ISBN 978-3-540-72813-9. PMID 18175099.
  67. ↑ Longo, LP; Johnson, B (2000). "Addiction: Part I. Benzodiazepines - side effects, abuse risk and alternatives". American Family Physician. 61 (7): 2121–2128. PMID 10779253. Archived from the original on 2008-05-12. Unknown parameter |deadurl= ignored (help)
  68. ↑ Ashton, HC (April 2001). "Reasons for a diazepam (Valium) taper". benzo.org.uk. Archived from the original on 2019-10-07. สืบค้นเมื่อ 2007-06-01. Unknown parameter |deadurl= ignored (help)
  69. ↑ MacKinnon, GL; Parker, WA (1982). "Benzodiazepine withdrawal syndrome: a literature review and evaluation". The American Journal of Drug and Alcohol Abuse. 9 (1): 19–33. doi:10.3109/00952998209002608. PMID 6133446.
  70. ↑ "Ativan Labeling Revision" (PDF). FDA. April 2007. Archived from the original (PDF) on 2008-03-07. สืบค้นเมื่อ 2007-10-03. Unknown parameter |deadurl= ignored (help)
  71. ↑ "Lorazepam: Patient Information Leaflet, UK, 1998". Genus Pharmaceuticals. 1998-01-21. สืบค้นเมื่อ 2007-05-14.
  72. ↑ "Lorazepam". Patient UK. 2006-10-25. Archived from the original on 2007-09-27. สืบค้นเมื่อ 2007-05-14. Unknown parameter |deadurl= ignored (help)
  73. ↑ Baciewicz, AM; Chrisman, CR; Finch, CK; Self, TH (2008). "Update on rifampin and rifabutin drug interactions". American Journal of the Medical Sciences. 335 (2): 126–136. doi:10.1097/MAJ.0b013e31814a586a. PMID 18277121.
  74. ↑ "Pharmacology of flumazenil". 1995. PMID 8693922. Cite journal requires |journal= (help)
  75. ↑ Contribution to the sensible use of benzodiazepines. Strassbourg: Council of Europe, Pompidou Group. 2002. ISBN 978-92-871-4751-6.
  76. ↑ Baselt, R (2008). Disposition of Toxic Drugs and Chemicals in Man (8th ed.). Foster City, CA: Biomedical Publications. pp. 860–862.
  77. ↑ Shaw, Leslie M. (2001). The Clinical Toxicology Laboratory: Contemporary Practice of Poisoning Evaluation (in อังกฤษ). Amer. Assoc. for Clinical Chemistry. p. 216. ISBN 9781890883539.
  78. ↑ Ries, Richard K.; Miller, Shannon C.; Fiellin, David A. (2009). Principles of Addiction Medicine (in อังกฤษ). Lippincott Williams & Wilkins. p. 301. ISBN 9780781774772.
  79. ↑ Mandrioli, R; Mercolini, L; Raggi, MA (2008). "Benzodiazepine metabolism: an analytical perspective". Current Drug Metabolism. 9 (8): 827–844. doi:10.2174/138920008786049258. PMID 18855614.
  80. ↑ Pompéia, S; Manzano, GM; Tufik, S; Bueno, OF (2005). "What makes lorazepam different from other benzodiazepines?". Journal of Physiology. 569 (Pt 2): 709, author reply 710. doi:10.1113/jphysiol.2005.569005. PMC 1464231. PMID 16322061.
  81. ↑ Chouinard, G (2004). "Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound". Journal of Clinical Psychiatry. 65 (Suppl 5): 7–12. PMID 15078112.
  82. ↑ British Medical Association and Royal Pharmaceutical Society of Great Britain (March 2007). British National Formulary (v53 ed.). London: BMJ and RPS Pub. ISBN 978-0-85369-731-2.
  83. ↑ Nimmo, R; Ashton, CH (March 2007). "Benzodiazepine Equivalence Table". benzo.org.uk. สืบค้นเมื่อ 2007-05-13.
  84. ↑ Ashton, CH (April 2007). "Benzodiazepine equivalency table". Archived from the original on 2007-09-28. สืบค้นเมื่อ 2007-09-23. Unknown parameter |deadurl= ignored (help)
  85. 1 2 3 4 5 "Lorzem Data Sheet". New Zealand Medicines and Medical Devices Safety Authority. 1999-06-04. Archived from the original on 2007-09-28. สืบค้นเมื่อ 2007-05-13. Unknown parameter |deadurl= ignored (help)
  86. ↑ Funderburk, FR; Griffiths, RR; McLeod, DR; Bigelow, GE; Mackenzie, A; Liebson, IA; Nemeth-Coslett, R (1988). "Relative abuse liability of lorazepam and diazepam: an evaluation in 'recreational' drug users". Drug and Alcohol Dependence. 22 (3): 215–222. doi:10.1016/0376-8716(88)90021-X. PMID 3234245.
  87. ↑ Lackner, TE (2002). "Strategies for optimizing antiepileptic drug therapy in elderly people". Pharmacotherapy. 22 (3): 329–364. doi:10.1592/phco.22.5.329.33192. PMID 11898891. Archived from the original on 2003-10-15. Unknown parameter |deadurl= ignored (help)
  88. ↑ Choudhery, V; Townend, W (2006). "Lorazepam or diazepam in paediatric status epilepticus". Emergency Medicine Journal. 23 (6): 472–473. doi:10.1136/emj.2006.037606. PMC 2564351. PMID 16714516. Archived from the original on 2007-10-14. Unknown parameter |deadurl= ignored (help)
  89. ↑ Henry, JC; Holloway, R (2006). "Review: lorazepam provides the best control for status epilepticus" (PDF). Evidence Based Medicine. 11 (2): 54. doi:10.1136/ebm.11.2.54. PMID 17213084. Archived from the original (PDF) on 2006-12-12. Unknown parameter |deadurl= ignored (help)
  90. ↑ Cock, HR; Schapira, AH (2002). "A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus". QJM. 95 (4): 225–231. doi:10.1093/qjmed/95.4.225. PMID 11937649. Archived from the original on 2007-05-28. Unknown parameter |deadurl= ignored (help)
  91. 1 2 3 Greenblatt, DJ; Schillings, RT; Kyriakopoulos, AA; Shader, RI; Sisenwine, SF; Knowles, JA; Ruelius, HW (1976). "Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam". Clinical Pharmacology and Therapeutics. 20 (3): 329–341. doi:10.1002/cpt1976203329. PMID 8232.
  92. ↑ Papini, O; Bertucci, C; da Cunha, SP; NA, dos Santos; Lanchote, VL (2006). "Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples". Journal of Pharmaceutical and Biomedical Analysis. 40 (2): 389–396. doi:10.1016/j.jpba.2005.07.033. PMID 16243469.
  93. ↑ Herman, RJ; Van Pham, JD; Szakacs, CB (1989). "Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect". Clinical Pharmacology and Therapeutics. 46 (1): 18–25. doi:10.1038/clpt.1989.101. PMID 2743706.
  94. ↑ Matthew, E; Andreason, P; Pettigrew, K; และคณะ (1995). "Benzodiazepine receptors mediate regional blood flow changes in the living human brain". Proc. Natl. Acad. Sci. U.S.A. 92 (7): 2775–2779. Bibcode:1995PNAS...92.2775M. doi:10.1073/pnas.92.7.2775. PMC 42301. PMID 7708722. Explicit use of et al. in: |last4= (help)
  95. ↑ Sybirska, E; Seibyl, JP; Bremner, JD; และคณะ (1993). "[123I]Iomazenil SPECT imaging demonstrates significant benzodiazepine receptor reserve in human and nonhuman primate brain". Neuropharmacology. 32 (7): 671–680. doi:10.1016/0028-3908(93)90080-M. PMID 8395663. Explicit use of et al. in: |last4= (help)
  96. ↑ McLean, MJ; Macdonald, RL (1988). "Benzodiazepines, but not beta-carbolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture". Journal of Pharmacology and Experimental Therapeutics. 244 (2): 789–795. PMID 2450203.
  97. ↑ "Lorazepam Injection Data Sheet" (PDF). Baxter International. Archived from the original (PDF) on 2007-05-07. Unknown parameter |deadurl= ignored (help)
  98. ↑ Yaucher, NE; Fish, JT; Smith, HW; Wells, JA (2003). "Propylene glycol-associated renal toxicity from lorazepam infusion". Pharmacotherapy. 23 (9): 1094–1099. doi:10.1592/phco.23.10.1094.32762. PMID 14524641.
  99. ↑ American Academy of Hospice and Palliative Medicine, "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American Academy of Hospice and Palliative Medicine, archived from the original on 2013-09-01, สืบค้นเมื่อ 2013-08-01 Unknown parameter |deadurl= ignored (help), which cites
    • Smith, T. J.; Ritter, J. K.; Poklis, J. L.; Fletcher, D.; Coyne, P. J.; Dodson, P.; Parker, G. (2012). "ABH Gel is Not Absorbed from the Skin of Normal Volunteers". Journal of Pain and Symptom Management. 43 (5): 961–966. doi:10.1016/j.jpainsymman.2011.05.017. PMID 22560361.
    • Weschules, D. J. (2005). "Tolerability of the Compound ABHR in Hospice Patients". Journal of Palliative Medicine. 8 (6): 1135–1143. doi:10.1089/jpm.2005.8.1135. PMID 16351526.
  100. ↑ Braestrup, C; Squires, RF (1978). "Pharmacological characterization of benzodiazepine receptors in the brain". European Journal of Pharmacology. 48 (3): 263–270. doi:10.1016/0014-2999(78)90085-7. PMID 639854.
  101. ↑ "Benzodiazepine Names". non-benzodiazepines.org.uk. Archived from the original on 2008-12-08. สืบค้นเมื่อ 2008-12-29. Unknown parameter |deadurl= ignored (help)
  102. ↑ Griffiths, RR; Johnson, MW (2005). "Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds". Journal of Clinical Psychiatry. 66 (Suppl 9): 31–41. PMID 16336040.
  103. ↑ "Drug Abuse Warning Network, 2006: National Estimates of Drug-Related Emergency Department Visits". Substance Abuse and Mental Health Services Administration. 2006. Archived from the original on 2014-03-16. สืบค้นเมื่อ 2014-02-21. Unknown parameter |deadurl= ignored (help)
  104. ↑ "List of psychotropic substances under international control: Green List 23rd ed" (PDF). Vienna: International Narcotics Control Board. August 2003. p. 7. Archived from the original (PDF) on 2005-12-05. Unknown parameter |deadurl= ignored (help)
  105. ↑ Labaton, S (2000-07-13). "Generic-Drug Maker Agrees to Settlement In Price-Fixing Case". The New York Times. Archived from the original on 2007-10-14. สืบค้นเมื่อ 2007-05-14. Unknown parameter |deadurl= ignored (help)

แหล่งที่มา

WikiPedia: ลอราเซแพม http://www.baxter.com/products/anesthesia/anesthet... http://ebm.bmj.com/cgi/reprint/11/2/54.pdf http://emj.bmj.com/cgi/content/extract/23/6/472 http://www.chemspider.com/Chemical-Structure.3821.... http://www.medscape.com/viewarticle/430209_3 http://www.medscape.com/viewarticle/489358 http://article.psychiatrist.com/?ContentType=START... http://www.rxlist.com/cgi/generic/loraz_ad.htm http://dgidb.genome.wustl.edu/drugs/DAP000237 http://www.accessdata.fda.gov/drugsatfda_docs/labe...